69640 Federal Register / Vol. 88, No. 193 / Friday, October 6, 2023 / Notices 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2023–22271 Filed 10–5–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-24–1402; Docket No. CDC–2023– 

0081] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed or continuing information 

collection, as required by the Paperwork 

Reduction Act of 1995. This notice 

invites comments on a proposed 

information collection titled 

Surveillance of HIV-related service 

barriers among Individuals with Early or 

Late HIV Diagnoses (SHIELD), which 

collects information from people who 

were recently diagnosed with HIV at 

early (Stage 0) or late diagnosis (Stage 3) 

to understand barriers to HIV 

prevention and testing services to 

contributing to transmission. 

DATES: CDC must receive written 

comments on or before December 5, 

2023. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2023– 

0081 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7118; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of the existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including using 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology, e.g., permitting 

electronic submissions of responses; 

and 

5. Assess information collection costs. 

Proposed Project 

Surveillance of HIV-related service 

barriers among Individuals with Early or 

Late HIV Diagnoses (SHIELD) (OMB 

Control No. 0920–1402, Exp. 5/31/ 

2026)—Revision—National Center for 

HIV, Viral Hepatitis, STD, and TB 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

National HIV Surveillance System 

(NHSS) data indicate that 37,968 

adolescents and adults received an HIV 

diagnosis in the United States and 

dependent areas in 2018. During 2015– 

2019, the overall rate of annual 

diagnoses decreased only slightly, from 

12.4 to 11.1 per 100,000. Although not 

every jurisdiction reports complete 

laboratory data needed to identify stage 

of infection, data from most 

jurisdictions show that many of these 

cases were classified as Stage 0 (7.9%) 

or Stage 3 (20.2%) infection (i.e., cases 

diagnosed in early infection or late 

infection, respectively). Early and late 

diagnoses represent recent failures in 

prevention and testing systems, 

respectively, and opportunities to 

understand needed improvements in 

these systems. 

The NHSS classifies HIV infections as 

Stage 0 if the first positive HIV test was 

within six months of a negative HIV 

test. Persons who received a diagnosis at 

Stage 0 (i.e., early diagnosis) were able 

to access HIV testing shortly after 

infection yet were unable to benefit 

from biomedical and behavioral 

interventions to prevent HIV infection. 

The federal Ending the HIV Epidemic in 

the U.S. (EHE) initiative prioritizes the 

provision of HIV preexposure 

prophylaxis (PrEP), syringe services 

programs, treatment as prevention 

efforts, and other proven 

interventions—as part of the Prevent 

pillar of the EHE initiative—to prevent 

new HIV infections. 

HIV infections are classified as Stage 

3 (AIDS) by the presence of an AIDSdefining opportunistic infection or by 

the lowest CD4 lymphocyte test result. 

Persons with Stage 3 infection at the 

time of their initial HIV diagnosis (i.e., 

late diagnosis) did not benefit from 

timely receipt of testing or HIV 

prevention interventions and were 

likely unaware of their infection for a 

substantial time. Nationally, an 

estimated 13.3% of persons with HIV 

are unaware of their infection, 

contributing to an estimated 40% of all 

ongoing transmission. Increasing early 

diagnosis is a crucial pillar of efforts to 

end HIV in the United States. Given the 

continued occurrence of HIV infections 

in the United States, the barriers and 

gaps associated with low uptake of HIV 

testing and prevention services must be 

addressed to reduce new infections and 

facilitate timely diagnosis and 

treatment. Therefore, CDC is sponsoring 

this data collection to improve 

understanding of barriers and gaps 

associated with new infection and late 

diagnosis in the era of multiple testing 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 193 / Friday, October 6, 2023 / Notices 69641 

modalities and prevention options such 

as PrEP. These enhanced surveillance 

activities will identify actionable missed 

opportunities for early diagnosis and 

prevention, thus informing the 

allocation of resources, development 

and prioritization of interventions, and 

evidence-based local and national 

decisions to improve HIV testing and 

address prevention gaps. 

The changes proposed in this 

Revision add a new qualitative data 

collection activity that encompasses a 

new consent form and a new data 

collection tool (in-depth interview 

guide) to conduct qualitative interviews 

to meet prevailing information needs 

and enhance the value of SHIELD data 

and minor edits to the approved 

SHIELD survey while remaining within 

the scope of the currently approved 

project purpose. The annualized burden 

hours of the project increased by 158 

hours with these additions, for a total of 

3,074 annualized burden hours. There is 

no cost to respondents other than their 

time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden 

per response 

(in hours) 

Total 

burden 

hours 

Potential Eligible Participant ............. Recruitment Script English ............... 2,000 1 15/60 500 

Potential Eligible Participant ............. Recruitment Script Spanish ............. 500 1 15/60 125 

Eligible Participant ............................ Consent for quantitative survey— 

English.

2,000 1 5/60 167 

Eligible Participant ............................ Consent for quantitative survey— 

Spanish.

500 1 5/60 42 

Eligible Participant ............................ Survey—English ............................... 2,000 1 50/60 1,666 

Eligible Participant ............................ Survey—Spanish .............................. 500 1 50/60 416 

Eligible Participant ............................ Consent for in-depth interview— 

English.

50 1 5/60 4 

Eligible Participant ............................ Consent for in-depth interview— 

Spanish.

50 1 5/60 4 

Eligible Participant ............................ In-depth Interview—English ............. 50 1 90/60 75 

Eligible Participant ............................ In-depth Interview—Spanish ............ 50 1 90/60 75 

Total ........................................... ........................................................... ........................ ........................ ........................ 3,074 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2023–22274 Filed 10–5–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Testing Identified Elements 

for Success in Fatherhood Programs 

(New Collection) 

AGENCY: Office of Planning, Research, 

and Evaluation, Administration for 

Children and Families, United States 

Department of Health and Human 

Services. 

ACTION: Request for public comments. 

SUMMARY: The Administration for 

Children and Families (ACF) Office of 

Planning, Research, and Evaluation 

(OPRE) launched the Testing Identified 

Elements for Success in Fatherhood 

Programs (Fatherhood TIES) project in 

2022. Using a mix of research methods, 

this study will identify and test the 

‘‘core components’’ of fatherhood 

programs in any effort to identify which 

core components are most effective at 

improving the lives of fathers who 

participate in fatherhood programs and 

their children. The study will ultimately 

include an implementation and an 

impact study. 

DATES: Comments due within 30 days of 

publication. In compliance with the 

requirements of the Paperwork 

Reduction Act of 1995, ACF is soliciting 

public comment on the specific aspects 

of the information collection described 

above. 

ADDRESSES: You can obtain copies of the 

proposed collection of information and 

submit comments by emailing 

OPREinfocollection@acf.hhs.gov. 

Identify all requests by the title of the 

information collection. 

SUPPLEMENTARY INFORMATION: 

Description: The proposed 

information collection request is to 

obtain consent to participate in the 

study, collect baseline information from 

program participants, and collect initial 

implementation study data. A future 

request will cover the remaining data 

collection materials associated with the 

impact and implementation studies. 

Core components are the essential 

functions, principles, and elements that 

are judged as being necessary to 

produce positive outcomes. Fatherhood 

programs usually offer workshops and 

case management services for fathers to 

provide, for example, parenting 

strategies to strengthen their 

relationships with their children, help 

finding a steady job, skills to enhance 

their relationships, and support dealing 

with other life or family challenges they 

might experience. Up to five Fatherhood 

Family—focused, Interconnected, 

Resilient, and Essential (Fatherhood 

FIRE) grant recipients will partner with 

the Fatherhood TIES study team to 

participate in an implementation and 

impact study. The implementation 

study will examine how the core 

components are implemented and what 

fathers think of them. The impact study 

will rigorously evaluate whether 

promising core components bring about 

positive outcomes for fathers and their 

families which may include 

understanding effects of program 

engagement, employment and earnings, 

father-child relationship quality and coparenting relationship quality. This 

notice is specific to data collection 

activities needed to collect consent of 

participants to enter the study, collect 

baseline information, and collect some 

implementation study data. A future 

notice will provide information about 

additional data collection activities for 

the impact and implementation studies. 


lotter on DSK11XQN23PROD with NOTICES1